Holli K - Search Results

1

Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer.

Järvinen TA, Pelto-Huikko M, Holli K, Isola J. Järvinen TA, et al. Among authors: holli k. Am J Pathol. 2000 Jan;156(1):29-35. doi: 10.1016/s0002-9440(10)64702-5. Am J Pathol. 2000. PMID: 10623650 Free PMC article.

2

Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer.

Siitonen SM, Kononen JT, Helin HJ, Rantala IS, Holli KA, Isola JJ. Siitonen SM, et al. Among authors: holli ka. Am J Clin Pathol. 1996 Apr;105(4):394-402. doi: 10.1093/ajcp/105.4.394. Am J Clin Pathol. 1996. PMID: 8604681

3

Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy.

Kuukasjärvi T, Kononen J, Helin H, Holli K, Isola J. Kuukasjärvi T, et al. Among authors: holli k. J Clin Oncol. 1996 Sep;14(9):2584-9. doi: 10.1200/JCO.1996.14.9.2584. J Clin Oncol. 1996. PMID: 8823339

4

Effect of age on the survival of breast cancer patients.

Holli K, Isola J. Holli K, et al. Eur J Cancer. 1997 Mar;33(3):425-8. doi: 10.1016/s0959-8049(97)89017-x. Eur J Cancer. 1997. PMID: 9155527

5

Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer.

Järvinen TA, Holli K, Kuukasjärvi T, Isola JJ. Järvinen TA, et al. Among authors: holli k. Br J Cancer. 1998 Jun;77(12):2267-73. doi: 10.1038/bjc.1998.377. Br J Cancer. 1998. PMID: 9649144 Free PMC article.

6

Low biologic aggressiveness in breast cancer in women using hormone replacement therapy.

Holli K, Isola J, Cuzick J. Holli K, et al. J Clin Oncol. 1998 Sep;16(9):3115-20. doi: 10.1200/JCO.1998.16.9.3115. J Clin Oncol. 1998. PMID: 9738583

7

Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study.

Joensuu H, Isola J, Lundin M, Salminen T, Holli K, Kataja V, Pylkkänen L, Turpeenniemi-Hujanen T, von Smitten K, Lundin J. Joensuu H, et al. Among authors: holli k. Clin Cancer Res. 2003 Mar;9(3):923-30. Clin Cancer Res. 2003. PMID: 12631589

8

Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients.

Isola J, Visakorpi T, Holli K, Kallioniemi OP. Isola J, et al. Among authors: holli k. J Natl Cancer Inst. 1992 Jul 15;84(14):1109-14. doi: 10.1093/jnci/84.14.1109. J Natl Cancer Inst. 1992. PMID: 1352359

9

Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer.

Kallioniemi OP, Holli K, Visakorpi T, Koivula T, Helin HH, Isola JJ. Kallioniemi OP, et al. Among authors: holli k. Int J Cancer. 1991 Nov 11;49(5):650-5. doi: 10.1002/ijc.2910490504. Int J Cancer. 1991. PMID: 1682277

10

Prognostic effect of timing of operation in relation to menstrual phase of breast cancer patient--fact or fallacy.

Holli K, Isola J, Hakama M. Holli K, et al. Br J Cancer. 1995 Jan;71(1):124-7. doi: 10.1038/bjc.1995.25. Br J Cancer. 1995. PMID: 7819026 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters